Aspire Biopharma, Stock Price Prediction
| ASBP Stock | 0.1 0 2.21% |
Momentum 31
Sell Stretched
Oversold | Overbought |
Using Aspire BioPharma, hype-based prediction, you can estimate the value of Aspire BioPharma, from the perspective of Aspire BioPharma, response to recently generated media hype and the effects of current headlines on its competitors.
Aspire BioPharma, Hype to Price Pattern
Investor biases related to Aspire BioPharma,'s public news can be used to forecast risks associated with an investment in Aspire. The trend in average sentiment can be used to explain how an investor holding Aspire can time the market purely based on public headlines and social activities around Aspire BioPharma,. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Aspire BioPharma,'s market sentiment to its price can help taders to make decisions based on the overall investors consensus about Aspire BioPharma,.
The fear of missing out, i.e., FOMO, can cause potential investors in Aspire BioPharma, to buy its stock at a price that has no basis in reality. In that case, they are not buying Aspire because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Aspire BioPharma, after-hype prediction price | USD 0.1 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Aspire BioPharma, Basic Forecasting Models to cross-verify your projections. Aspire BioPharma, After-Hype Price Prediction Density Analysis
As far as predicting the price of Aspire BioPharma, at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Aspire BioPharma, or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Aspire BioPharma,, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Aspire BioPharma, Estimiated After-Hype Price Volatility
In the context of predicting Aspire BioPharma,'s stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Aspire BioPharma,'s historical news coverage. Aspire BioPharma,'s after-hype downside and upside margins for the prediction period are 0.01 and 16.45, respectively. We have considered Aspire BioPharma,'s daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Aspire BioPharma, is out of control at this time. Analysis and calculation of next after-hype price of Aspire BioPharma, is based on 3 months time horizon.
Aspire BioPharma, Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Aspire BioPharma, is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Aspire BioPharma, backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Aspire BioPharma,, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
1.05 | 16.35 | 0.00 | 0.11 | 7 Events / Month | 5 Events / Month | In about 7 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.1 | 0.10 | 3.09 |
|
Aspire BioPharma, Hype Timeline
Aspire BioPharma, is presently traded for 0.1. The entity stock is not elastic to its hype. The average elasticity to hype of competition is -0.11. Aspire is forecasted to increase in value after the next headline, with the price projected to jump to 0.1 or above. The average volatility of media hype impact on the company the price is insignificant. The price gain on the next news is projected to be 3.09%, whereas the daily expected return is presently at -1.05%. The volatility of related hype on Aspire BioPharma, is about 15571.43%, with the expected price after the next announcement by competition of -0.01. Aspire BioPharma, currently holds 1.27 M in liabilities. Given the investment horizon of 90 days the next forecasted press release will be in about 7 days. Check out Aspire BioPharma, Basic Forecasting Models to cross-verify your projections.Aspire BioPharma, Related Hype Analysis
Having access to credible news sources related to Aspire BioPharma,'s direct competition is more important than ever and may enhance your ability to predict Aspire BioPharma,'s future price movements. Getting to know how Aspire BioPharma,'s peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Aspire BioPharma, may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| PALI | Palisade Bio | (0.05) | 10 per month | 5.67 | 0.21 | 19.05 | (8.97) | 64.37 | |
| CRIS | Curis Inc | (0.04) | 8 per month | 0.00 | (0.14) | 8.33 | (8.13) | 27.78 | |
| LPTX | LPTX Old | 0.01 | 9 per month | 6.90 | 0.14 | 25.00 | (9.43) | 65.13 | |
| ENTO | Entero Therapeutics, | (0.17) | 10 per month | 7.81 | 0.08 | 16.50 | (17.06) | 56.75 | |
| CTXR | Citius Pharmaceuticals | (0.03) | 9 per month | 5.46 | (0) | 13.83 | (9.49) | 36.73 | |
| DARE | Dare Bioscience | (0.11) | 10 per month | 3.74 | 0.01 | 6.55 | (5.73) | 26.52 | |
| BCTX | Briacell Therapeutics Corp | (0.46) | 7 per month | 0.00 | (0.02) | 13.96 | (8.95) | 35.24 | |
| PCSA | Processa Pharmaceuticals | (0.15) | 8 per month | 12.95 | 0.05 | 28.94 | (15.49) | 164.28 | |
| ADTX | Aditxt Inc | (0.03) | 9 per month | 0.00 | (0.42) | 19.39 | (28.09) | 63.67 | |
| HOTH | Hoth Therapeutics | (0.02) | 8 per month | 0.00 | (0.24) | 5.26 | (6.94) | 17.14 |
Aspire BioPharma, Additional Predictive Modules
Most predictive techniques to examine Aspire price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Aspire using various technical indicators. When you analyze Aspire charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Aspire BioPharma, Predictive Indicators
The successful prediction of Aspire BioPharma, stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Aspire BioPharma,, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Aspire BioPharma, based on analysis of Aspire BioPharma, hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Aspire BioPharma,'s market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Aspire BioPharma,'s related companies.
Story Coverage note for Aspire BioPharma,
The number of cover stories for Aspire BioPharma, depends on current market conditions and Aspire BioPharma,'s risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Aspire BioPharma, is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Aspire BioPharma,'s long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Aspire BioPharma, Short Properties
Aspire BioPharma,'s future price predictability will typically decrease when Aspire BioPharma,'s long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Aspire BioPharma, often depends not only on the future outlook of the potential Aspire BioPharma,'s investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Aspire BioPharma,'s indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 47.6 M | |
| Cash And Short Term Investments | 3633.00 |
Additional Tools for Aspire Stock Analysis
When running Aspire BioPharma,'s price analysis, check to measure Aspire BioPharma,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aspire BioPharma, is operating at the current time. Most of Aspire BioPharma,'s value examination focuses on studying past and present price action to predict the probability of Aspire BioPharma,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aspire BioPharma,'s price. Additionally, you may evaluate how the addition of Aspire BioPharma, to your portfolios can decrease your overall portfolio volatility.